79 related articles for article (PubMed ID: 26087991)
1. Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes.
Ratovitski EA
Curr Pharm Biotechnol; 2015; 16(9):832-50. PubMed ID: 26087991
[TBL] [Abstract][Full Text] [Related]
2. Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure.
Ratovitski EA
FEBS Lett; 2015 May; 589(12):1352-8. PubMed ID: 25910754
[TBL] [Abstract][Full Text] [Related]
3. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
4. Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death.
Ratovitski EA
FEBS Lett; 2013 Aug; 587(16):2536-41. PubMed ID: 23831023
[TBL] [Abstract][Full Text] [Related]
5. Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.
Huang Y; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Mar; 11(6):1247-59. PubMed ID: 22356768
[TBL] [Abstract][Full Text] [Related]
6. Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.
Ratovitski EA
FEBS Lett; 2013 Nov; 587(21):3581-6. PubMed ID: 24070899
[TBL] [Abstract][Full Text] [Related]
7. Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.
Huang Y; Kesselman D; Kizub D; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2013 Feb; 12(4):684-97. PubMed ID: 23343772
[TBL] [Abstract][Full Text] [Related]
8. Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.
Huang Y; Chuang AY; Ratovitski EA
Cell Cycle; 2011 Nov; 10(22):3938-47. PubMed ID: 22071691
[TBL] [Abstract][Full Text] [Related]
9. Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.
Ratovitski EA
Cell Cycle; 2014; 13(5):749-61. PubMed ID: 24394434
[TBL] [Abstract][Full Text] [Related]
10. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells.
Huang Y; Chuang A; Hao H; Talbot C; Sen T; Trink B; Sidransky D; Ratovitski E
Cell Death Differ; 2011 Jul; 18(7):1220-30. PubMed ID: 21274007
[TBL] [Abstract][Full Text] [Related]
11. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
[TBL] [Abstract][Full Text] [Related]
12. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
13. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.
Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C
BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497
[TBL] [Abstract][Full Text] [Related]
14. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
17. Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA.
Chen JJ; Liu SX; Chen MZ; Zhao ZY
Mol Med Rep; 2015 Sep; 12(3):3569-3574. PubMed ID: 26017674
[TBL] [Abstract][Full Text] [Related]
18. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
Lu L; Zhang X; Zhang B; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
[TBL] [Abstract][Full Text] [Related]
19. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
20. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
